RY 167.32 0.7952% SHOP 156.84 0.1852% TD 87.295 0.6979% ENB 63.73 0.5522% BN 79.19 -0.1387% TRI 247.45 0.7082% CNQ 44.49 0.9301% CP 103.64 -1.267% CNR 140.22 -0.7573% BMO 140.7 0.8674% BNS 69.62 0.6069% CSU 4745.0 0.3269% CM 83.02 0.6791% MFC 45.15 0.512% ATD 70.57 0.6992% NGT 68.24 1.8052% TRP 70.02 -0.7653% SU 54.83 -0.4177% WCN 275.71 0.9224% L 195.87 1.6292%
GSK plc (NYSE: GSK)
GSK plc (NYSE: GSK) is an international biopharmaceutical company with two primary divisions: Commercial Operations and Research & Development. It specializes in developing treatments for various cancers, including ovarian cancer, endometrial cancer, and multiple myeloma. Its diverse product portfolio encompasses vaccines, specialty medicines, and general medicines, catering to unmet medical needs in respiratory and inflammatory diseases.
As per our previous US Dailies report published on ‘GSK’ on 5th Feb 2025, Kalkine provided an ‘Buy’ stance on the stock at USD 34.84 based on fundamental analysis and the stock price has now moved by ~15.93% since then and is hovering around resistance 2.
Noted below are the details of support and resistance levels provided in our previous report:
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA
AU
UK
US
NZ
Please wait processing your request...